Invitrogen™ H-cadherin Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5114998

Catalog No. PIPA5114998

Description

Antibody detects endogenous levels of total CDH13.

The protein encoded by this gene has a C-terminal domain with tRNA 3 processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene.

Specifications

• Antigen: H-cadherin
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: CDH13
• Gene Alias: 4932416G01Rik; CAD13; cadherin 13; cadherin 13, H-cadherin (heart); cadherin-13; CD39 antigen-like 3; CD39L3; CD39-like 3; CDH13; CDHH; Cdht; ecto-apyrase 3; ecto-ATPase 3; ecto-ATPDase 3; HB6; H-cadherin; H-cadherin (heart); heart cadherin; heart-cadherin; NTPDase 3; NTPDase-3; P105; T cad; T Cadherin; Tcad; T-cad; T-cadherin; Truncated cadherin; truncated-cadherin
• Host Species: Rabbit
• Purification Method: Affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 1012, 12554
• Content And Storage: -20°C
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide
• Gene Accession No.: P55290, Q9WTR5
• Gene Symbols: CDH13
• Immunogen: A synthesized peptide derived from human CDH13(Accession P55290), corresponding to amino acid residues P144-T194.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov